"Abstract
Background: During the COVID-19 vaccination campaign in Sweden, pulmonary embolism (PE) was a frequently reported suspected serious adverse drug reaction. The aim was to estimate risk of PE following vaccination for COVID-19 in the Swedish population aged 18 to 84 years ...
Results
The total population, 12–84 years old consisted of 7,513,618 individuals (49.7 % women) observed for 13,087,019 person years at risk (PYAR). Eighty percent of the study-population, 6,072,228 individuals received at least two doses of COVID-19 vaccine, i.e. the primary vaccinations scheme and 12,456 cases of PE were identified during the study period. Three percent of PE cases died within 30 days (n = 374) from PE-diagnosis."
© 2024 The Author(s)
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).